Print
The Vermont Statutes Online
Title
08
:
Banking and Insurance
Chapter
129
:
INSURANCE TRADE PRACTICES
§
4724. Unfair methods of competition or unfair or deceptive acts or practices
defined
The following
are hereby defined as unfair methods of competition or unfair or deceptive acts
or practices in the business of insurance:
(1)
Misrepresentations and false advertising of insurance policies. Making,
issuing, circulating, or causing to be made, issued, or circulated, any
estimate, illustration, circular, statement, sales presentation, omission, or
comparison which:
(A)
misrepresents or fails to adequately disclose the benefits, advantages,
conditions, exclusions, limitations, or terms of any insurance policy; or
(B)
misrepresents the dividends or share of the surplus to be received on any
insurance policy; or
(C) makes any
false or misleading statements as to the dividends or share of surplus
previously paid on any insurance policy; or
(D) is
misleading or is a misrepresentation as to the financial condition of any
person, or as to the legal reserve system upon which any life insurer operates;
or
(E) uses any
name or title of any insurance policy or class of insurance policies
misrepresenting the true nature thereof; or
(F) is a
misrepresentation for the purpose of inducing or tending to induce the lapse,
forfeiture, exchange, conversion, or surrender of any insurance policy; or
(G) is a
misrepresentation for the purpose of effecting a pledge or assignment of or
effecting a loan against any insurance policy; or
(H)
misrepresents any insurance policy as being shares of stock.
(2) False
information and advertising generally. Making, publishing, disseminating,
circulating, or placing before the public or causing, directly or indirectly,
to be made, published, disseminated, circulated, or placed before the public,
in a newspaper, magazine, or other publication, in the form of a notice,
circular, pamphlet, letter, or poster or over any radio station or television
station, or in any other way, an advertisement, announcement, or statement
containing any assertion, representation, or statement with respect to the business
of insurance or with respect to any person in the conduct of his or her
business, which is untrue, deceptive, or misleading.
(3) Defamation.
Making, publishing, disseminating, or circulating, directly or indirectly, or
aiding, abetting, or encouraging the making, publishing, disseminating, or
circulating of any oral or written statement or any pamphlet, circular, article
or literature which is false, or maliciously critical of or derogatory to the
financial condition of any person and which is calculated to injure such
person.
(4)(A) Boycott,
coercion, and intimidation. Entering into any agreement to commit, or by any
concerted action committing any act of boycott, coercion, or intimidation
resulting in or tending to result in unreasonable restraint of trade, or
monopoly in, the business of insurance.
(B) Committing
any act of boycott, coercion, or intimidation in the marketing or sale of any
insurance contracts.
(5) False
financial statements and entries.
(A) Knowingly
filing with any supervisory or other public official, or knowingly making,
publishing, disseminating, circulating, or delivering to any person, or placing
before the public, or knowingly causing directly or indirectly, to be made,
published, disseminated, circulated, delivered to any person, or placed before
the public, any false material statement of fact as to the financial condition
of a person.
(B) Knowingly
making any false entry of a material fact in a book, report, or statement of
any person or knowingly omitting to make a true entry of any material fact
pertaining to the business of such person in any book, report, or statement of
such person.
(C) Knowingly
concealing, withholding or destroying, mutilating, altering, or by any means
falsifying any documentary material in the possession, custody, or control of
any person after that person:
(i) has received
a complaint to which that documentary material is directly relevant; or
(ii) knows that
the documentary material is relevant to an investigation or an examination of
that person being made by the Commissioner.
(6) Stock
operations and advisory board contracts. Permitting agents, officers, or
employees to issue or deliver agency or company stock or other capital stock,
or benefit certificates or share in any common-law corporation, or securities
or any special or advisory board contracts or other contracts of any kind
promising returns and profits as an inducement to insure.
(7) Unfair
discrimination; arbitrary underwriting action.
(A) Making or
permitting any unfair discrimination between insureds of the same class and
equal risk in the rates charged for any contract of insurance, or in the
dividends or other benefits payable thereon, or in any other of the terms and
conditions of such contracts.
(B) Making or
permitting unfair discrimination against an applicant or an insured, on the
basis of the sex, sexual orientation, gender identity, or marital status of the
applicant or insured, with regard to:
(i) Underwriting
standards and practices or eligibility requirements; or
(ii) Rates;
however, nothing in this subdivision shall prevent any person who contracts to
insure another from setting rates for such insurance in accordance with
reasonable classifications based on relevant actuarial data or actual cost
experience in accordance with section 4656 of this title.
(C)(i) Inquiring
or investigating, directly or indirectly as to an applicant's, an insured's or
a beneficiary's sexual orientation, or gender identity in an application for
insurance coverage, or in an investigation conducted by an insurer, reinsurer,
or insurance support organization in connection with an application for such
coverage, or using information about gender, marital status, medical history,
occupation, residential living arrangements, beneficiaries, zip codes, or other
territorial designations to determine sexual orientation or gender identity;
(ii) Using
sexual orientation, gender identity, or beneficiary designation in the
underwriting process or in the determination of insurability;
(iii) Making
adverse underwriting decisions because medical records or a report from an
insurance support organization reveal that an applicant or insured has
demonstrated AIDS-related concerns by seeking counseling from health care
professionals;
(iv) Making
adverse underwriting decisions on the basis of the existence of nonspecific
blood code information received from the medical information bureau or a
national data bank, but this prohibition shall not bar investigation in
response to such a nonspecific blood code;
(v) The
provisions of this subdivision (C) shall not be construed to prohibit an
insurer from requesting an applicant or insured to take an HIV-related test on
the basis of the health history or current condition of health of the applicant
or insured in accordance with the provisions of subdivision (20) of this
section.
(D) Making or
permitting any unfair discrimination against any individual by conditioning
insurance rates, the provision or renewal of insurance coverage, or other
conditions of insurance based on medical information, including the results of
genetic testing, where there is not a relationship between the medical
information and the cost of the insurance risk that the insurer would assume by
insuring the proposed insured. In demonstrating the relationship, the insurer
can rely on actual or reasonably anticipated experience. As used in this
subdivision, "genetic testing" shall be defined as the term is
defined in 18 V.S.A. § 9331(7).
(E) Making or
permitting unfair discrimination between married couples and parties to a civil
union as defined under 15 V.S.A. § 1201, with regard to the offering of
insurance benefits to a couple, a spouse, a party to a civil union, or their
family. The Commissioner shall adopt rules necessary to carry out the purposes
of this subdivision. The rules shall ensure that insurance contracts and
policies offered to married couples, spouses, and families are also made
available to parties to a civil union and their families. The Commissioner may
adopt by order standards and a process to bring the forms currently on file and
approved by the Department into compliance with Vermont law. The standards and
process may differ from the provisions contained in chapter 101, subchapter 6,
and sections 4062, 4201, 4515a, 4587, 4685, 4687, 4688, 4985, 5104, and 8005 of
this title where, in the Commissioner's opinion, the provisions regarding
filing and approval of forms are not desirable or necessary to effectuate the
purposes of this section.
(8) Rebates.
(A) Except as
otherwise expressly provided by law, knowingly permitting or offering to make
or making any contract of insurance or agreement as to such contract other than
as plainly expressed in the insurance contract issued thereon, or paying or
allowing, or giving or offering to pay, allow, or give, directly or indirectly,
as inducement to such insurance, any rebate or premiums payable on the
contract, or any special favor or advantage in the dividends or other benefits
thereon, or any valuable consideration or inducement whatever not specified in
the contract; or giving, or selling, or purchasing or offering to give, sell,
or purchase as inducement to such insurance contract or annuity or in
connection therewith, any stocks, bonds, or other securities of any insurance
company or other corporation, association, or partnership, or any dividends or
profits accrued thereon, or anything of value whatsoever of value not specified
in the contract.
(B) Making
available through any rating plan or form, property, casualty, or surety
insurance to any firm, corporation, or association of individuals, any
preferred rate or premium based upon any fictitious grouping of such firm,
corporation, or individuals. The grouping of risks by way of membership,
nonmembership, license, franchise, employment, contract, agreement, or any
other method or means, when the grouping of risks have no preferred
characteristic over similar risks written on an individual basis, for the
purpose of insuring such grouped risks at a preferred rate or premium or on a
preferred form is a "fictitious grouping." This subdivision shall not
apply to life or health and disability insurance or annuity contracts.
(C) Nothing in
subdivision (7) or (8)(A) of this section shall be construed as including
within the definition of discrimination or rebates any of the following
practices:
(i) in the case
of any contract of life insurance or life annuity, paying bonuses to
policyholders or otherwise abating their premiums in whole or in part out of
surplus accumulated from nonparticipating insurance, provided that such bonuses
or abatement of premiums shall be fair, and equitable to policyholders and for
the best interest of the company and its policyholders;
(ii) in the case
of life insurance policies issued on the industrial debit plan, making
allowance to policyholders who have continuously for a specified period made
premium payments directly to an office of the insurer in an amount which fairly
represents the saving in collection expenses;
(iii)
readjustment of the rate of premium for a group insurance policy based on the
loss or expense thereunder, at the end of the first or any subsequent policy
year of insurance thereunder, which may be made retroactive only for such
policy year.
(9) Unfair claim
settlement practices. Committing or performing with such frequency as to
indicate a business practice any of the following:
(A)
misrepresenting pertinent facts or insurance policy provisions relating to
coverage at issue;
(B) failing to
acknowledge and act reasonably promptly upon communications with respect to claims
arising under insurance policies;
(C) failing to
adopt and implement reasonable standards for the prompt investigation of claims
arising under insurance policies;
(D) refusing to
pay claims without conducting a reasonable investigation based upon all available
information;
(E) failing to
affirm or deny coverage of claims within a reasonable time after proof of loss
statements have been completed;
(F) not
attempting in good faith to effectuate prompt, fair, and equitable settlements
of claims in which liability has become reasonably clear;
(G) attempting
to settle a claim for less than the amount to which a reasonable person would
have believed he or she was entitled by reference to written or printed
advertising material accompanying or made a part of the application;
(H) attempting
to settle claims on the basis of an application which was altered without
notice to, or knowledge or consent of the insured;
(I) making claim
payments to insureds or beneficiaries not accompanied by a statement setting
forth the coverage under which the payments are made;
(J) making known
to insureds or claimants a policy of appealing from arbitration awards in favor
of insureds or claimants for the purpose of compelling them to accept
settlements or compromises less than the amount awarded in arbitration;
(K) delaying the
investigation or payment of claims by requiring an insured, claimant, or the
physician of either to submit a preliminary claim report and then requiring the
subsequent submission of formal proof of loss forms, both of which submissions
contain substantially the same information;
(L) failing to
promptly settle claims where liability has become reasonably clear under one
portion of the insurance policy coverage in order to influence settlements
under other portions of the insurance policy coverage;
(M) failing to
promptly provide a reasonable explanation on the basis in the insurance policy
in relation to the facts or applicable law for denial of a claim or for the
offer of a compromise settlement.
(10) Failure to
maintain complaint handling procedures. Failure of any person to maintain a
complete record of all of the complaints which it has received since the date
of its last examination under section 3563 or 3564 of this title. This record
shall indicate the total number of complaints, their classification by line of
insurance, the nature of each complaint, the disposition of these complaints,
the time it took to process each complaint, and such other information as the
Commissioner may require. As used in this subdivision, "complaint"
shall mean any written communication primarily expressing a grievance.
(11)
Misrepresentation in insurance applications. Making false or fraudulent
statements or representations on or relative to an application for an insurance
policy, for the purpose of obtaining a fee, commission, money, or other benefit
from any insurers, agent, broker, or individual.
(12) Failure of
agent, broker, or insurer to act as fiduciary. Failure of any insurance agent,
broker, or insurer to act as a fiduciary in regard to premiums, return premiums
or other sums of money received by him or her in his or her capacity as
insurance agent, insurance broker, or insurer by failure to pay or transmit in
a timely manner those sums of money to the persons to whom it is owed.
(13)
Misrepresentation of services or products. Any person offering his or her, or
its services or insurance policies to the public in such a way as to mislead or
to fail to adequately disclose to the public the true nature of the policies or
the services offered.
(14)
Nondisclosure of fees or charges. Failure of any agent or broker to obtain a
prior written agreement with a client, policyholder, or other member of the
public concerning fees or charges made by that agent or broker directly to the client,
policyholder, or member of the public for that agent or broker procuring,
servicing, or providing advice on insurance contracts. Commissions, expense
allowances, bonuses, fees, or any other compensation received directly by
agents or brokers from any legal entity engaged in the insurance business is
exempt from this subdivision.
(15) Financed
premiums. Misrepresenting or failing to completely disclose the terms,
conditions, or benefits of financing premiums for insurance policies where the
financing of the premiums constitute part of the solicitation or sale of the
policy.
(16) Unsuitable
policies. Soliciting, selling, or issuing an insurance policy when the person
soliciting, selling, or issuing the policy has reason to know or should have
reason to know that it is unsuitable for the person purchasing it.
(17) Failure to
instruct or supervise representatives. Failure of an employer or principal
engaged in the business of insurance to instruct or supervise any full-time
agent, or full-time adjuster, or full or part-time employee after that employer
or principal has knowledge of a deceptive or unfair act or practice prohibited
by this chapter which was committed by that agent, adjuster, or employee.
(18) Doing
business with a person known to be committing deceptive or unfair acts or using
prohibited practices. Accepting business from or contracting with or continuing
contractual relations with a person whom the other person knows or has or
should have reason to know is repeatedly committing deceptive or unfair acts or
practices prohibited by this title.
(19) Failure to
comply with filed rates, rules, regulations, or forms. Failure to comply with
any rates, rules, regulations, or forms filed with the Commissioner.
(20) HIV-related
tests. Failing to comply with the provisions of this subdivision regarding
HIV-related tests. "HIV-related test" means a test approved by the
United States Food and Drug Administration and the Commissioner, used to
determine the existence of HIV antibodies or antigens in the blood, urine, or
oral mucosal transudate (OMT).
(A) No person
shall request or require that a person reveal having taken HIV-related tests in
the past.
(B)(i) No person
shall request or require that an individual submit to an HIV-related test
unless he or she has first obtained the individual's written informed consent
to the test. Before written, informed consent may be granted, the individual
shall be informed, by means of a printed information statement which shall have
been read aloud to the individual by any agent of the insurer at the time of
application or later and then given to the individual for review and retention,
of the following:
(I) an
explanation of the test or tests to be given, including: the tests'
relationship to AIDS, the insurer's purpose in seeking the test, potential uses
and disclosures of the results, limitations on the accuracy of and the meaning
of the test's results, the importance of seeking counseling about the
individual's test results after those results are received, and the availability
of information from and the telephone numbers of the Vermont AIDS hotline and
the Centers for Disease Control and Prevention; and
(II) an
explanation that the individual is free to consult, at personal expense, with a
personal physician or counselor or the State Department of Health, or obtain an
anonymous test at the individual's choice and personal expense, before deciding
whether to consent to testing and that such delay will not affect the status of
any application or policy; and
(III) a summary
of the individual's rights under this subdivision (20), including subdivisions
(F)-(K); and
(IV) an
explanation that the person requesting or requiring the test, not the
individual or the individual's health care provider, will be billed for the
test, that the individual has a choice to receive the test results directly or
to designate in writing prior to the administration of the test any other
person through whom to receive the results, and any HIV positive test result
from a test performed pursuant to this subdivision (20) shall be reported to
the Vermont Department of Health pursuant to 18 V.S.A. § 1001.
(ii) In
addition, before drawing blood or obtaining a sample of the urine or OMT for
the HIV-related test or tests, the person doing so shall give the individual to
be tested an informed consent form containing the information required by the
provisions of this subdivision (B), and shall then obtain the individual's
written informed consent. If an OMT test is administered in the presence of the
agent or broker, the individual's written informed consent need only be
obtained prior to administering the test, in accordance with the provisions of
this subdivision (B).
(C)(i) The forms
for informed consent, information disclosure, and test results disclosure used
for HIV-related testing shall be filed with and approved by the Commissioner
pursuant to section 3541 of this title; and
(ii) Any testing
procedure shall be filed and approved by the Commissioner in consultation with
the Commissioner of Health.
(D) No
laboratory may be used by an insurer or insurance support organization for the
processing of HIV-related tests unless it is approved by the Vermont Department
of Health. Any requests for approval under this subdivision shall be acted upon
within 120 days. The Department may approve a laboratory without on-site
inspection or additional proficiency data if the laboratory has been certified
under the Clinical Laboratory Improvement Act, 42 U.S.C. § 263a or if it meets
the requirements of the federal Health Care Financing Administration under the
Clinical Laboratory Improvement Amendments.
(E) The test
protocol shall be considered positive only if test results are two positive
ELISA tests, and a Western Blot test confirms the results of the two ELISA
tests, or upon approval of any equally or more reliable confirmatory test or
test protocol which has been approved by the Commissioner and the U.S. Food and
Drug Administration. If the result of any test performed on a sample of urine
or OMT is positive or indeterminate, the insurer shall provide to the
individual, no later than 30 days following the date of the first urine or OMT
test results, the opportunity to retest once, and the individual shall have the
option to provide either a blood sample, a urine sample, or an OMT sample for
that retest. This retest shall be in addition to the opportunities for retest
provided in subdivisions (F) and (G) of this subdivision (20).
(F) If an
individual has at least two positive ELISA tests but an indeterminate Western
Blot test result, the Western Blot test may be repeated on the same sample. If
the Western Blot test result is indeterminate, the insurer may delay action on
the application, but no change in preexisting coverage, benefits, or rates
under any separate policy or policies held by the individual may be based upon
such indeterminacy. If action on an application is delayed due to indeterminacy
as described herein, the insurer shall provide the individual the opportunity
to retest once after six but not later than eight months following the date of
the first indeterminate test result. If the retest Western Blot test result is
again indeterminate or is negative, the test result shall be considered as
negative, and a new application for coverage shall not be denied by the insurer
based upon the results of either test. Any underwriting decision granting a
substandard classification or exclusion based on the individual's prior
HIV-related test results shall be reversed, and the company performing a retest
which had forwarded to a medical information bureau reports based upon the
individual's prior HIV-related test results shall request the medical
information bureau to remove any abnormal codes listed due to such prior test
results.
(G)(i) Upon the
written request of an individual for a retest, an insurer shall retest, at the
insurer's expense, any individual who was denied insurance, or offered
insurance on any other than a standard basis, because of the positive results
of an HIV-related test:
(I) once within
the three-year period following the date of the most recent test; and
(II) in any
event, upon the approval by the Commissioner of an alternative test or test
protocol for the presence of HIV antibodies or antigens.
(ii) If such
retest is negative, a new application for coverage shall not be denied by the
insurer based upon the results of the initial test. Any underwriting decision
granting a substandard classification or exclusion based on the individual's
prior HIV-related test results shall be reversed, and the company performing a
retest which had forwarded to a medical information bureau reports based upon
the individual's prior HIV-related test results shall request the medical
information bureau to remove any abnormal codes listed due to such prior test
results.
(H) An insurer,
on the basis of the individual's written informed consent as specified in
subdivision (B) of this subdivision, if necessary to make underwriting
decisions regarding the particular individual's application, may disclose the
results of an individual's HIV-related test results to its reinsurers, or to
those contractually retained medical personnel, laboratories, insurance support
organizations, and insurance affiliates (but not agents or brokers) that are
involved in underwriting decisions regarding the individual's particular
application. Other than the disclosures permitted by this subdivision, the
entities listed herein, including the insurer, shall not further disclose to
anyone individually identified HIV-related test result information without a
separately obtained written authorization from the individual; provided,
however, that if an individual's test result is positive or indeterminate, then
an insurer may report a code to the medical information bureau provided that a
nonspecific test result code is used which does not indicate that the
individual was subjected to HIV-related testing.
(I) An insurer,
reinsurer, contractually retained medical personnel, laboratories, medical
information bureau, or other national data bank, insurance affiliate, or
insurance support organizations that are obligated not to disclose any
individually-identifiable records of HIV-related tests pursuant to this
subdivision (20) shall have no duty to disclose this information to any person
except in compliance with a court order or as provided in subdivision (B) or
(H) nor shall it have any liability to any person for refusing or failing to
disclose such information.
(J) Any
individual who sustains damage as a result of the unauthorized negligent or
knowing disclosure of that individual's individually-identifiable HIV-related
test result information in violation of subdivision (H) of this subdivision
(20) may bring an action for appropriate relief in Superior Court against any
person making such a disclosure. The Court may award costs and reasonable
attorney's fees to the individual who prevails in an action brought under this
subdivision.
(K) In addition
to any other remedy or sanction provided by law, after notice and opportunity
for hearing the Commissioner may assess an administrative penalty in an amount
not to exceed $2,000.00 for each violation against any person who violates any
provision of this subdivision (20) or subdivision (7)(C) of this section.
(21) Automobile
glass services. In the case of claims for damage to automobile glass under a
policy of insurance covering, in whole or in part, motor vehicles:
(A) Failing to
inform an insured, at the time a claim is made, of the right of the insured to
choose freely any company or location for providing automobile glass services.
(B)
Intimidating, coercing, threatening, or misinforming an insured for the purpose
of inducing the insured to use a particular company or location to provide
automobile glass services.
(22) Genetic
testing.
(A) Conditioning
insurance rates, the provision or renewal of insurance coverage or benefits or
other conditions of insurance for any individual on:
(i) any
requirement or agreement of the individual to undergo genetic testing; or
(ii) the results
of genetic testing of a member of the individual's family unless the results
are contained in the individual's medical record.
(B) As used in
this subdivision, "genetic testing" shall be defined as the term is
defined in 18 V.S.A. § 9331(7). (Amended 1967, No. 186, eff. April 17, 1967;
1973, No. 216 (Adj. Sess.), § 4, eff. May 1, 1974; 1975, No. 180 (Adj. Sess.);
1979, No. 28, § 5; 1987, No. 194 (Adj. Sess.), §§ 1, 2; 1991, No. 135 (Adj.
Sess.), § 7; 1991, No. 194 (Adj. Sess.); 1997, No. 160 (Adj. Sess.), § 5a, eff.
Jan. 1, 1999; 1999, No. 91 (Adj. Sess.), § 17, eff. Jan. 1, 2001; 2001, No. 23,
§ 1; 2007, No. 41, § 9; 2007, No. 73, § 3, eff. April 1, 2008.)